Search Results

There are 19428 results for: content related to: The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1 / BRCA2 mutation carriers

  1. You have free access to this content
    Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ

    Cancer

    Volume 118, Issue 6, 15 March 2012, Pages: 1515–1522, Soley Bayraktar, Nisreen Elsayegh, Angelica M. Gutierrez Barrera, Heather Lin, Henry Kuerer, Tunc Tasbas, Kimberly I. Muse, Kaylene Ready, Jennifer Litton, Funda Meric-Bernstam, Gabriel N. Hortobagyi, Constance T. Albarracin and Banu Arun

    Version of Record online : 25 AUG 2011, DOI: 10.1002/cncr.26428

  2. You have free access to this content
    Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis

    International Journal of Cancer

    Volume 136, Issue 3, 1 February 2015, Pages: 668–677, Bernadette A.M. Heemskerk-Gerritsen, Matti A. Rookus, Cora M. Aalfs, Margreet G.E.M. Ausems, Johanna M. Collée, Liesbeth Jansen, C. Marleen Kets, Kristien B.M.I. Keymeulen, Linetta B. Koppert, Hanne E.J. Meijers-Heijboer, Thea M. Mooij, Rob A.E.M. Tollenaar, Hans F.A. Vasen, HEBON, Maartje J. Hooning and Caroline Seynaeve

    Version of Record online : 8 JUL 2014, DOI: 10.1002/ijc.29032

  3. You have free access to this content
    Improved survival in women with BRCA-associated ovarian carcinoma

    Cancer

    Volume 97, Issue 9, 1 May 2003, Pages: 2187–2195, Ilana Cass, Rae Lynn Baldwin, Taz Varkey, Roxana Moslehi, Steven A. Narod and Beth Y. Karlan

    Version of Record online : 17 APR 2003, DOI: 10.1002/cncr.11310

  4. You have free access to this content
    Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer

    BJU International

    Volume 109, Issue 5, March 2012, Pages: 713–719, David J. Gallagher, Angel M. Cronin, Matthew I. Milowsky, Michael J. Morris, Jasmine Bhatia, Peter T. Scardino, James A. Eastham, Kenneth Offit and Mark E. Robson

    Version of Record online : 14 JUL 2011, DOI: 10.1111/j.1464-410X.2011.10292.x

  5. You have free access to this content
    Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer

    Cancer

    Volume 118, Issue 15, 1 August 2012, Pages: 3703–3709, David M. Hyman, Qin Zhou, Alexia Iasonos, Rachel N. Grisham, Angela G. Arnold, Mary F. Phillips, Jasmine Bhatia, Douglas A. Levine, Carol Aghajanian, Kenneth Offit, Richard R. Barakat, David R. Spriggs and Noah D. Kauff

    Version of Record online : 2 DEC 2011, DOI: 10.1002/cncr.26655

  6. Genotype in BRCA-associated Breast Cancers

    The Breast Journal

    Volume 19, Issue 1, January/February 2013, Pages: 87–91, Funda Meric-Bernstam, Angelica M. Gutierrez-Barrera, Jennifer Litton, Lauren Mellor-Crummey, Kaylene Ready, Ana Maria Gonzalez-Angulo, Karen H. Lu, Gabriel N. Hortobagyi and Banu K. Arun

    Version of Record online : 10 DEC 2012, DOI: 10.1111/tbj.12056

  7. You have free access to this content
    Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico

    Cancer

    Volume 121, Issue 3, February 1, 2015, Pages: 372–378, Cynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, Luis A. Herrera, Josef Herzog, Danielle Castillo, Alejandro Mohar, Clementina Castro, Lenny N. Gallardo, Dolores Gallardo, Miguel Santibáñez, Kathleen R. Blazer and Jeffrey N. Weitzel

    Version of Record online : 18 SEP 2014, DOI: 10.1002/cncr.29058

  8. You have free access to this content
    Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 493–499, Zsofia K. Stadler, Erin Salo-Mullen, Sujata M. Patil, M. Catherine Pietanza, Joseph Vijai, Emmanouil Saloustros, Nichole A. L. Hansen, Noah D. Kauff, Robert C. Kurtz, David P. Kelsen, Kenneth Offit and Mark E. Robson

    Version of Record online : 19 MAY 2011, DOI: 10.1002/cncr.26191

  9. BRCA-mutated Invasive Breast Carcinomas: Immunohistochemical Analysis of Insulin-like Growth Factor II mRNA-binding Protein (IMP3), Cytokeratin 8/18, and Cytokeratin 14

    The Breast Journal

    Volume 21, Issue 6, November/December 2015, Pages: 596–603, Sambit K. Mohanty, Jin-Ping Lai, Ora K. Gordon, Dinesh Pradhan, Shikha Bose and Farnaz Dadmanesh

    Version of Record online : 22 SEP 2015, DOI: 10.1111/tbj.12494

  10. Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

    International Journal of Cancer

    Volume 137, Issue 5, 1 September 2015, Pages: 1136–1146, Joanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, Cezary Cybulski, Rochelle Demsky, Susan L. Neuhausen, Charmaine Kim-Sing, Nadine Tung, Susan Friedman, Leigha Senter, Jeffrey Weitzel, Beth Karlan, Pal Moller, Ping Sun, Steven A. Narod and the Hereditary Breast Cancer Clinical Study Group

    Version of Record online : 18 DEC 2014, DOI: 10.1002/ijc.29386

  11. You have free access to this content
    Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer

    Cancer

    Volume 119, Issue 7, 1 April 2013, Pages: 1344–1348, Susan M. Domchek, Komal Jhaveri, Sujata Patil, Jill E. Stopfer, Clifford Hudis, Jacquelyn Powers, Zsofia Stadler, Laura Goldstein, Noah Kauff, Mustafa Khasraw, Kenneth Offit, Katherine L. Nathanson and Mark Robson

    Version of Record online : 16 NOV 2012, DOI: 10.1002/cncr.27842

  12. Twenty-one–gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status

    Cancer

    Volume 122, Issue 8, April 15, 2016, Pages: 1178–1184, Payal D. Shah, Sujata Patil, Maura N. Dickler, Kenneth Offit, Clifford A. Hudis and Mark E. Robson

    Version of Record online : 9 FEB 2016, DOI: 10.1002/cncr.29903

  13. You have free access to this content
    The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers

    Cancer

    Volume 118, Issue 4, 15 February 2012, Pages: 899–907, Mieke Kriege, Agnes Jager, Maartje J. Hooning, Elisabeth Huijskens, Jannet Blom, Carolien H. M. van Deurzen, Marijke Bontenbal, J. Margriet Collee, Marian B. E. Menke-Pluijmers, John W. M. Martens and Caroline Seynaeve

    Version of Record online : 14 JUL 2011, DOI: 10.1002/cncr.26351

  14. Identification of BRCA1-deficient ovarian cancers

    Acta Obstetricia et Gynecologica Scandinavica

    Volume 90, Issue 6, June 2011, Pages: 593–599, ANNE-BINE SKYTTE, MARIANNE WALDSTRØM, ANDERS AAMANN RASMUSSEN, DORTHE CRÜGER, EMMA R. WOODWARD and STEEN KØLVRAA

    Version of Record online : 15 APR 2011, DOI: 10.1111/j.1600-0412.2011.01121.x

  15. Hereditary gynaecological malignancies: advances in screening and treatment

    Histopathology

    Volume 62, Issue 1, January 2013, Pages: 2–30, Ann K Folkins and Teri A Longacre

    Version of Record online : 13 DEC 2012, DOI: 10.1111/his.12028

  16. You have free access to this content
    BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

    Cancer

    Volume 104, Issue 12, 15 December 2005, Pages: 2807–2816, Tuya Pal, Jenny Permuth-Wey, Judith A. Betts, Jeffrey P. Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A. Martino, Katie Wakeley, George Wilbanks, Santo Nicosia, Alan Cantor and Rebecca Sutphen

    Version of Record online : 14 NOV 2005, DOI: 10.1002/cncr.21536

  17. You have free access to this content
    Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations

    Cancer

    Volume 97, Issue 7, 1 April 2003, Pages: 1601–1608, Noah D. Kauff, Edi Brogi, Lauren Scheuer, Dorothy R. Pathak, Patrick I. Borgen, Clifford A. Hudis, Kenneth Offit and Mark E. Robson

    Version of Record online : 18 MAR 2003, DOI: 10.1002/cncr.11225

  18. You have free access to this content
    TP53 mutations in familial breast cancer: Functional aspects

    Human Mutation

    Volume 21, Issue 3, March 2003, Pages: 301–306, Milena Gasco, Isik G Yulug and Tim Crook

    Version of Record online : 24 FEB 2003, DOI: 10.1002/humu.10173

  19. Prolonged survival among women with BRCA germline mutations and advanced endometrial cancer: a case series

    International Journal of Gynecological Cancer

    Volume 18, Issue 3, May/June 2008, Pages: 546–549, J. S. KWON, J. LENEHAN, M. CAREY and P. AINSWORTH

    Version of Record online : 21 JUL 2007, DOI: 10.1111/j.1525-1438.2007.01030.x

  20. Identification of germline genetic mutations in patients with pancreatic cancer

    Cancer

    Volume 121, Issue 24, 15 December 2015, Pages: 4382–4388, Erin E. Salo-Mullen, Eileen M. O'Reilly, David P. Kelsen, Asad M. Ashraf, Maeve A. Lowery, Kenneth H. Yu, Diane L. Reidy, Andrew S. Epstein, Anne Lincoln, Amethyst Saldia, Lauren M. Jacobs, Rohini Rau-Murthy, Liying Zhang, Robert C. Kurtz, Leonard Saltz, Kenneth Offit, Mark E. Robson and Zsofia K. Stadler

    Version of Record online : 6 OCT 2015, DOI: 10.1002/cncr.29664